Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,958 total articles
Fulcrum Therapeutics, a clinical-stage biopharmaceutical company focused on rare hematological disorders, will release its Q1 2026 financial results on April 27, 2026, prior to market open. Management will hold a conference call and webcast at 8:00 a.m. ET to discuss the results and corporate updates, including progress on their lead program, pocir…
Amneal Pharmaceuticals announced encouraging interim data from its ongoing Phase 4 ELEVATE-PD study evaluating CREXONT®, an extended-release carbidopa/levodopa formulation for Parkinson's disease. Among 111 patients switching from existing therapies such as IR CD/LD and RYTARY®, CREXONT significantly increased daily 'Good On' time by approximately …
Abacus Global Management, a NYSE-listed alternative asset management company, announced its participation in the 2026 Milken Institute Global Conference. The company's CEO will discuss key trends impacting private wealth, including aging populations, the great wealth transfer, and AI's role in financial advice. Abacus management will also engage in…
Phathom Pharmaceuticals announced it will report its Q1 2026 financial results and provide a business update via a live webcast on April 30, 2026. The company focuses on developing and commercializing novel gastrointestinal disease treatments, including its marketed product VOQUEZNA for GERD and H. pylori infection treatment in the U.S.
LENZ Therapeutics has submitted a Marketing Authorization Application to the UK's MHRA for VIZZ®, an FDA-approved aceclidine-based eye drop for presbyopia treatment. This marks the sixth regulatory submission outside the US as LENZ advances international commercialization efforts following positive Phase 3 trial results and early US market launch.
Beyond Air's subsidiary, Beyond Cancer, presented updated Phase 1 clinical data for its investigational immunotherapy UNO at AACR 2026, reporting prolonged survival in heavily pretreated cancer patients after a single intratumoral injection. The trial included patients with breast cancer, squamous cell carcinoma, and melanoma, many of whom had exha…
Allogene Therapeutics presented new scientific data and advancements at the AACR 2026 Annual Meeting, emphasizing the potential of their allogeneic CAR T cell therapies to provide off-the-shelf, scalable, and accessible treatment options for cancer and autoimmune diseases. The company showcased dual-targeting technology and expanded their pipeline,…
Fortuna Mining Corp., a Canadian precious metals miner listed on the NYSE and TSX, has entered into an earn-in agreement with Qstone Inc. to acquire up to a 70% interest in the Quartzstone Project, a 29,600-hectare land package in Guyana's highly prospective gold-rich greenstone belt. Historical drilling reveals multiple zones of high-grade near-su…
BlackRock Asset Management Canada, a subsidiary of BlackRock, Inc., announced the cash distributions payable in April 2026 for various iShares exchange-traded funds listed on the TSX and Cboe Canada, including both bond and equity ETFs. The distributions apply to unitholders of record as of April 27, 2026, with payments on April 30, 2026. Distribut…
Silvaco Group, Inc. announced a strategic partnership with Taiwan's Industrial Technology Research Institute (ITRI) to deploy Silvaco's SmartSpice circuit simulation solution within ITRI's Nankang IC Design Incubation Center. This collaboration aims to support advanced microcontroller unit (MCU) development and accelerate startup innovation in semi…
Super League Enterprise, Inc. announced a shareholder letter encouraging support for its acquisition of the Misfits Ads Division. The acquisition is expected to add profitable revenue, improve financial predictability, expand market share, and speed the company's path to sustainable cash-based EBITDA profitability. The transaction diversifies reven…
Immuneering Corporation presented new genetic data at the AACR Annual Meeting demonstrating that their MEK inhibitor, atebimetinib, rarely induces common resistance mutations in the MAPK pathway in treated patients. This supports the drug's potential for durable tumor shrinkage and improved survival in first-line pancreatic cancer. The company is a…
Inspired Entertainment, a US-listed provider of B2B gaming content and systems, has launched its premium iGaming portfolio in South Africa through partnerships with key local operators like Hollywood Bets and Betway. Enabled by its agreement with Light & Wonder, this move marks a significant expansion into a growing and regulated South African iGam…
FreightCar America, a leading North American manufacturer of railroad freight cars and related services, announced it will release its Q1 2026 financial results on May 4, 2026, followed by a teleconference on May 5 to discuss the results. The company specializes in the production, repair, and conversion of freight railcars, emphasizing their role i…
First Tracks Biotherapeutics, a clinical-stage biotech company focused on antibody therapies for autoimmune and inflammatory diseases, officially launched as an independent public company on Nasdaq under the ticker TRAX. The company has a strong financial foundation with $180 million in cash and a two-year cash runway. Its pipeline features three d…
GBank Financial Holdings Inc. will release its first quarter 2026 financial results on April 29, 2026, followed by a quarterly earnings call hosted remotely. The company is a Nasdaq-listed bank holding company focused on gaming fintech and SBA lending, with operations spanning four states in the U.S.
Kroll Bond Rating Agency (KBRA) has affirmed Preferred Bank's deposit and debt ratings with a stable outlook, highlighting the bank's robust profitability, high-yield loan portfolio, and efficient branch-light business model. The strong 2025 return on assets (ROA) of 1.84% underpins these ratings. Preferred Bank continues to serve a diverse custome…
PDF Solutions, a Nasdaq-listed company specializing in data solutions for the semiconductor industry, will release its first quarter fiscal 2026 financial results after market close on May 7, 2026. The company's CEO and CFO will host a live teleconference to discuss the results, accessible via webcast and phone.
ServisFirst Bancshares, Inc. announced robust financial results for Q1 2026, highlighting a 31% increase in diluted earnings per share to $1.52 compared to Q1 2025, improved net interest margin of 3.53%, and strong loan and deposit growth. The bank's efficiency ratio improved to under 30%, and key capital ratios strengthened, reflecting sound finan…
Biodesix, Inc., a diagnostic solutions company, will report its first quarter 2026 financial results on May 4, 2026, after market close. The company will hold a conference call to discuss the results and provide a business update. Biodesix offers diagnostic tests for lung disease and supports biopharmaceutical development efforts.
Radware Ltd. announces its 2026 Annual General Meeting (AGM) to be held on May 25, 2026, at its New Jersey office. The agenda includes electing Class III directors, approving equity awards and bonus structure for the CEO, and reappointing the audit firm Kost Forer Gabbay & Kasierer. Financial statements for 2025 will also be presented and discussed…
Parsons Corporation has been selected by the Los Angeles Department of Water & Power (LADWP) to implement its Demand Response Management System (DRMS), significantly boosting LADWP's capacity to integrate distributed energy resources as part of its strategic plan to achieve 100% clean electricity by 2035 or sooner. This contract will enhance grid r…
Ascentage Pharma presented four preclinical studies at AACR 2026 demonstrating the efficacy and synergistic potential of its drug candidates Olverembatinib, APG-2449, and APG-5918 in treating various cancers. These findings support further clinical development and combination therapy strategies for hematologic malignancies and solid tumors, highlig…
ANI Pharmaceuticals announces FDA approval and commercial launch of Pimozide Tablets (1 mg and 2 mg), a generic version of Orap®, with 180-day exclusivity for first generic competition. The product targets a market with approximate annual U.S. sales of $3.1 million, supporting ANI's strategy to deliver limited competition generic products and expan…
Fiserv, Inc., a leading global provider of payments and financial services technology, announced its CEO Mike Lyons will present at major upcoming investor conferences in May, including the J.P. Morgan Global Technology, Media, and Communications Conference and the Bernstein Strategic Decisions Conference. The presentations will be webcast and avai…
